Announcements
Open Access
Conference Report
The 21st International Conference on Progress in Vaccination against Cancer (PIVAC-22), September 26–28, 2022, Turin, Italy
Show Less
1
Anatomy Department, Tehran University of Medical Sciences, 1417653761 Tehran, Iran
2
Molecular Biotechnology Center “Guido Tarone'', Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy
*Correspondence: federica.cavallo@unito.it (Federica Cavallo)
†These authors contributed equally.
Academic Editor: Roberto Bei
†These authors contributed equally.
Academic Editor: Roberto Bei
Front. Biosci. (Landmark Ed) 2022, 27(12), 338;
https://doi.org/10.31083/j.fbl2712338
Submitted: 17 December 2022 | Accepted: 23 December 2022 | Published: 29 December 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract
The 21st international congress on Progress in Vaccination against Cancer (PIVAC-22, https://www.pivac22.it/) was held from September 26 to September 28, 2022, at the Molecular Biotechnology Center “Guido Tarone” in Turin, Italy. The meeting covered the most recent advances in the field of cancer immunotherapy, with a focus on the tumor microenvironment, and addressed how alterations to the microenvironment’s molecular and metabolic features and the microbiota impact upon the response to immunotherapy.
Keywords
PIVAC-22
cancer vaccination
immunotherapy
tumor microenvironment
immune resistance
microbiota